At the @-year clinical follow-up ( @ % of patients ) , the main clinical outcome measure ( composite of cardiac death , myocardial infarction , and target vessel revascularization ) was significantly reduced in the EES arm ( @ % vs. @ % ; p = @ ; hazard ratio : @ ; @ % CI : @ to @ ) , mainly driven by a lower need for target vessel revascularization ( @ % vs. @ % ; p = @ ) .